Type 1 Diabetes Glycemic Control Improved During Pandemic Lockdown
On average, glycemic control improved during lockdown among people living with type 1 diabetes.
On average, glycemic control improved during lockdown among people living with type 1 diabetes.
The FDA has approved the first generic equivalent of Glucagon Emergency Kit (Lilly), according to Amphastar Pharmaceuticals.
Investigators advocate for a staging system that keeps pace with the current body of knowledge.
For patients with diabetes hospitalized with COVID-19, the risk for intubation is increased more than fivefold for those with diabetic retinopathy.
Whether successful treatment of depression reduces the risk for progression needs to be determined.
Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.
A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals.
Investigators sought to determine whether younger age at diagnosis, female sex, and higher weight z score and HbA1c are risk factors for C-peptide decline after new onset of pediatric type 1 diabetes.
The study goal was to determine whether real-time continuous glucose monitoring up to 24 months is beneficial, particularly in persons living with impaired awareness of hypoglycemia.
The BLA is supported by data from a phase 2 trial that evaluated whether teplizumab could prevent or delay the onset of T1D in at-risk individuals.